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Abstract: Although seizures are frequently seen after cerebrovascular accidents, their effects on
long-term outcome in stroke patients are still unknown. Therefore, the aim of this study was to
investigate the relationship between post-stroke seizures and the risk of long-term disability and
mortality in stroke patients. This study is part of a larger population-based study. All patients were
prospectively followed up by a face-to-face interview or a structured telephone interview. We enrolled
635 patients with first-ever stroke and without a history of seizures. Prevalence of ischemic stroke (IS)
was 85.2%, while the remaining 14.8% of patients were affected by intracerebral hemorrhage (ICH).
During the study period, 51 subjects (8%) developed post-stroke seizures. Patients with post-stroke
seizures were younger, had a higher prevalence of ICH, had a more severe stroke at admission, were
more likely to have an IS involving the total anterior circulation, and were more likely to have a
lobar ICH than patients without seizures. Moreover, subjects with seizures had more frequently
hemorrhagic transformation after IS and cortical strokes. At 24 months, the risk of disability in
patients with seizures was almost twice than in those without seizures. However, the negative effect
of seizures disappeared in multivariate analysis. Kaplan-Meier survival curves at 12 years were
not significantly different between patients with and without post-stroke seizures. Using the Cox
multivariate analysis, age, NIHSS at admission, and pre-stroke mRS were independently associated
with all-cause long-term mortality. In our sample, seizures did not impair long-term outcome in
patients affected by cerebrovascular accidents. The not significant, slight difference in favor of a
better survival for patients with seizures may be attributed to the slight age difference between the
two groups.
Keywords: acute stroke; post-stroke seizures; long-term outcome; disability; mortality
1. Introduction
Seizures are frequently seen after cerebrovascular accidents. Acute symptomatic or early seizures
(ES) affect between 3% and 6% of all stroke patients [1–6], whereas unprovoked or late seizures (LS)
have been reported in 10 to 12% of stroke patients [7,8].
Although determinants and correlates of ES and LS after stroke have been largely
investigated [1,6,9–17], the effect of seizures on long-term outcome in stroke patients is still unknown.
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In fact, previous studies focused their interest on short-term mortality [2,12,18–22], and only a few of
them reported results on disability that was assessed only at discharge [13,18,19,21,22].
Recently, Claessens et al. conducted a retrospective study to explore a possible association between
post-stroke seizures and long-term mortality. After correction for possible confounding variables, the
authors concluded that seizures were not significantly related to mortality risk [23]. Conversely, in the
prospective Future study, Arntz et al. showed that post-stroke seizures negatively affect long-term
disability and mortality [24,25]. Differences in the population study might explain these conflicting
findings. In particular, Claessens et al. included only patients with intracerebral hemorrhage (ICH),
whereas Arntz et al. included only young patients, aged 18 to 50 years, after transient ischemic attack
(TIA), ischemic stroke (IS) or ICH [23–25]. Bearing in mind that ICH accounts for almost 15% of all
strokes and that cerebrovascular accidents are largely more common in subjects older than 50 years,
these results cannot be directly generalizable to all stroke patients.
Therefore, the aim of this study was to investigate the relationship between post-stroke seizures
and the risk of long-term disability and mortality in patients affected by cerebrovascular accidents.
2. Methods
2.1. Study Population
This survey is part of a larger population-based study on the incidence and outcome of
cerebrovascular disease in the district of Udine, Friuli-Venezia-Giulia region, Italy [26,27]. In short,
this study comprises all cases of incident or recurrent TIA and strokes occurring in the Udine district
between 1 April 2007 and 31 March 2009. Previous results on cumulative incidence and short-term
mortality (at one month and 24 months) of post-stroke seizures have been published [6]. For the
present study we included patients with first-ever stroke and without a history of seizures. According
to the World Health Organization definition, stroke was defined as acute symptoms and/or signs
of focal disturbance of cerebral function lasting >24 h or leading to death with no apparent cause
other than that of vascular origin [28]. Exclusion criteria were TIA, traumatic hemorrhagic stroke,
hemorrhage in known cerebral metastasis or primary brain tumor, cerebral venous sinus thrombosis,
any subarachnoid hemorrhage or ICH due to known ruptured aneurysm, and retinal infarction.
The study was approved by our local Ethics Committee. Informed consent was obtained from the
patients or their representatives.
2.2. Assessment of Post-Stroke Seizures
Seizures were defined according to International League Against Epilepsy (ILAE) criteria as
paroxysmal disorders of the central nervous system, followed or not by loss of consciousness and/or
with or without motor involvement [29]. The seizure type was described following the most recent
classification of the ILAE [30]. Based on post-stroke seizures occurrence, patients were divided into
SZR + (patients with post-stroke seizures) and SZR − (patients without post-stroke seizures) groups.
The SZR + group comprised subjects with both ES and LS. Information on the use of antiepileptic
drugs (AEDs) was recorded.
2.3. Data Collection
Baseline characteristics such as demographic data, vascular risk factor, and laboratory findings
were collected. A CT or MRI brain scan was performed to distinguish IS from ICH and to identify
stroke subtypes. IS subtypes were classified according to the TOAST (Trial of ORG 10172 in Acute
Stroke Treatment) criteria (large artery atherosclerosis, cardioembolism, small-vessel occlusion,
other determined etiology, and undetermined etiology) [31] and to the Oxfordshire Community
Stroke Project (OCSP) criteria—total anterior circulation infarction (TACI), partial anterior circulation
infarction (PACI), posterior circulation infarct (POCI), or lacunar infarct (LACI) [32]. Based on ICH
location we distinguished lobar and deep ICH. Data on reperfusion therapy in patients with IS,
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hemorrhagic transformation after IS, and cortical location of cerebrovascular lesion were collected.
However, the number of reperfused patients is very limited due to the fact that our center, at that
time, was still at the beginning with this expertise. Stroke severity was determined with the National
Institute of Health Stroke Scale (NIHSS) score at admission [33]. Functional outcome was assessed by
means of the modified Rankin Scale (mRS) at admission based on pre-stroke disability, one month,
six months, and 24 months after stroke [34]. The mRS score was dichotomized into favorable outcome
(0–2) and poor outcome (3–6).
High blood pressure was defined as systolic pressure ≥140 mm Hg and/or diastolic pressure
≥90 mm Hg, and/or use of antihypertensive medication, and/or being told at least twice by a physician
or other health professional that high blood pressure was the diagnosis. Atrial fibrillation was
diagnosed if patient had atrial fibrillation in ECG recording before stroke and/or during hospitalization.
Diabetes mellitus was defined as history of diabetes that was confirmed in medical records, and/or
use of insulin/oral hypoglycemic agents, and/or random non-fasting blood glucose concentration
≥11.1 mmol/L. Hypercholesterolemia was defined as fasting total cholesterol serum level ≥5.18 mmol/L
(200 mg/dL), and/or fasting low-density lipoprotein cholesterol serum level of≥4.14 mmol/L (160 mg/dL),
and/or use of lipid-lowering medications. Patients were defined as smokers if they were current
smokers or they had stopped smoking <3 months before the index stroke.
The following abnormalities in laboratory parameters were collected: hypo- and hypernatremia,
defined as sodium values <135 mmol/L and >145 mmol/L, respectively; hypo- and hyperkalemia,
defined as potassium values <3.5 mmol/L and >5.1 mmol/L, respectively; and hypo- and hyperglycemia,
defined as glucose values <3.9 mmol/L and >11.1 mmol/L, respectively.
2.4. Follow-Up
All patients were followed up by a face-to-face interview at one month, six months, and 24 months
after stroke. At the follow-up, the occurrence of seizures, the beginning of AEDs, and the mRS were
assessed. The next follow-up assessment was performed between January 2018 and December 2018 by
means of a structured telephone interview to evaluate the occurrence of seizures. Before contacting the
patient, the hospital records were reviewed for diagnosis of seizures. In case a patient had died, further
information on the occurrence of seizures was retrieved from the general practitioner (GP). When
patient or GP reported the occurrence of seizures, an experienced neurologist verified the diagnosis
and retrieved information on AEDs.
2.5. Outcome Measures
The primary endpoints were
(1) Poor outcome at 24 months, as assessed by the mRS;
(2) All-cause long-term mortality. Information on the permanence in life was systematically recorded
thanks to the use of death certificates.
2.6. Statistical Analysis
The two patient groups (SZR + versus SZR −) were compared regarding baseline characteristics,
and rate of poor outcome at 24 months. Differences between the two groups were assessed by means
of the chi-square test (Fisher’s exact test) for categorical variables and Student t test for independent
samples when continuous variables had a normal distribution. The Mann–Whitney U test was used
when continuous variables had an abnormal distribution and for ordinal variables. The association
between post-stroke seizures and poor outcome was examined by binary logistic regression modeling,
after adjusting for the other variables with a probability value <0.1 in univariate analysis. Long-term
mortality was estimated with the Kaplan-Meier analysis for patients with and without post-stroke
seizures. Independent predictors of mortality were detected by means of a Cox multivariate model
that included age, sex, presence of post-stroke seizures, presence of IS or ICH, NIHSS at admission,
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and pre-stroke mRS, as covariates. Finally, we compared by means of the chi-square test the long-term
disability and mortality between each group of patients, identified according to the specific type of
post-stroke seizure, and the subjects without seizures. Data are displayed in tables as means and
standard deviations (SD), if not otherwise specified. All probability values are two-tailed. A p value
<0.05 was considered statistically significant. Statistical analysis was carried out using the IBMSPSS
Statistics, Version 22.0 (IBM, Chicago, IL, USA).
3. Results
3.1. Study Population
Six hundred and thirty-five patients with first ever stroke entered the study (Figure 1). Prevalence
of IS was 85.2% (n = 541), while the remaining 14.8% (n = 94) of patients was affected by ICH. Median
NIHSS score at admission was 5 (IQR 2-15). One hundred and forty-one patients (22.2%) had a
pre-stroke mRS >2. During the study period, 51 subjects (8%) developed post-stroke seizures, i.e., focal
aware in 15 (29.4%), generalized tonic-clonic in 15 (29.4%), focal to bilateral tonic-clonic in 11 (21.6%),
and focal impaired awareness in 10 (19.6%). AEDs were started in 21 patients (41.2%).
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According to baseline characteristics, patients with post-stroke seizures differed significantly from
those without seizures (see Table 1). They were younger, had a higher prevalence of ICH, had a more
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severe stroke at admission, were more likely to have an IS involving the total anterior circulation based
on OCSP classification, and to have a lobar ICH. Moreover, subjects with seizures had more frequently
hemorrhagic transformation after IS (SZR +: 31.4% versus SZR −: 13.7%, p = 0.005) and cortical strokes
(SZR +: 52.9% versus SZR −: 32.5%, p = 0.003) than those without seizures. Although very limited
in its numerosity, prevalence of rt-PA use for IS did not differ between patients with and without
seizures (SZR +: 0% versus SZR −: 2.4%, p = 0.4). No patient was treated, at that time, with mechanical
thrombectomy for IS.




(n = 584) p
Demographic Data and Baseline Clinical Characteristics
Age, years 72.3 ± 14.8 77.5 ± 11.5 0.003
Males, n (%) 21 (41.2) 276 (47.3) 0.4
Stroke subtypes 0.001
IS, n (%) 35 (68.6) 506 (86.6)
ICH, n (%) 16 (31.4) 78 (13.4)
IS subtypes based on TOAST classification 0.08
Large artery atherosclerosis, n (%) 2 (5.7) 58 (11.5)
Cardioembolism, n (%) 9 (25.7) 98 (19.4)
Small-vessel occlusion, n (%) 1 (2.9) 82 (16.2)
Other determined etiology, n (%) 2 (5.7) 9 (1.8)
Undetermined etiology, n (%) 21 (60) 259 (51.2)
IS subtypes based on OCSP classification 0.001
TACI, n (%) 9 (25.7) 36 (7.1)
PACI, n (%) 22 (62.9) 270 (53.4)
POCI, n (%) 1 (2.9) 86 (17)
LACI, n (%) 3 (8.6) 114 (22.5)
ICH localization 0.01
Lobar, n (%) 9 (56.3) 18 (23.1)
Deep, n (%) 7 (43.8) 60 (76.9)
NIHSS score at admission, median (IQR) 10 (4–17) 5 (2–14) 0.01
pre-stroke mRS, median (IQR) 0 (0-2) 0 (0-2) 0.2
Vascular risk factors
Hypertension, n (%) 37 (72.5) 475 (81.3) 0.9
Atrial fibrillation, n (%) 17 (33.3) 195 (33.4) 0.4
Diabetes mellitus, n (%) 11 (21.6) 140 (24.0) 0.7
Hypercholesterolemia, n (%) 13 (25.5) 140 (24.0) 0.8
Smoking, n (%) 9 (17.6) 101 (17.3) 0.9
Laboratory findings
Sodium 0.3
Hyponatremia, n (%) 7 (13.7) 45 (7.7)
Hypernatremia, n (%) 1 (2.0) 8 (1.4)





(n = 584) p
Laboratory findings
Potassium 0.4
Hypokalemia, n (%) 5 (9.8) 98 (16.8)
Hyperkalemia, n (%) 4 (7.8) 37 (6.3)
Glucose 0.2
Hypoglycemia, n (%) 0 (0) 0 (0)
Hyperglycemia, n (%) 37 (72.5) 370 (63.4)
SZR +: patients with post-stroke seizures; SZR −: patients without post-stroke seizures; IS = ischemic stroke; ICH:
intracranial hemorrhage; TOAST: Trial of ORG 10,172 in Acute Stroke Treatment; OCSP: Oxfordshire Community
Stroke Project; TACI: total anterior circulation infarction; PACI: partial anterior circulation infarction; POCI: posterior
circulation infarct; LACI: lacunar infarct; NIHSS: National Institute of Health Stroke Scale; mRS = modified
Rankin Scale.
3.2. Long-Term Functional Outcome
At 24 months, 419 patients (66%) had a poor outcome, 40 (9.5%) of whom had seizures. There
were 216 patients (44%) without disability, and 11 (5.1%) of them had seizures. As reported in Table 2,
several variables were associated with long-term disability in univariate analysis. In particular, the risk
of poor functional outcome in patients with seizures was almost twice than in those without seizures.
The negative effect of seizures disappeared in multivariate analysis that identified age, ICH, and NIHSS
at admission as independent predictors of 24 months disability.
Table 2. Predictors of long-term disability.
Unadjusted Analysis Multivariate Analysis *
OR 95% CI p OR 95% CI p
Age 1.08 1.07–1.10 0.001 1.09 1.06–1.12 0.001
Sex
Females 1.00
Males 0.43 0.30–0.57 0.001 0.96 0.60–1.54 0.9
Post–stroke seizures
No 1.00
Yes 1.97 1.01–3.92 0.05 2.29 0.80–6–56 0.1
Stroke subtypes
IS 1.00
ICH 1.96 1.17–3.82 0.01 3.01 1.50–6.07 0.002
Small–vessel occlusion based on
TOAST classification
No 1.00
Yes 0.17 0.10–0.29 0.001 0.58 0.21–1–60 0.3
Undetermined etiology based on
TOAST classification
No 1.00
Yes 3.28 2.27–4.74 0.001 1.99 0.98–4.01 0.06
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Table 2. Cont.
Unadjusted Analysis Multivariate Analysis *
OR 95% CI p OR 95% CI p
TACI based on OCSP classification
No 1.00
Yes 6.42 2.26–18–20 0.001 1.12 0.33–3.85 0.8
LACI based on OCSP classification
No 1.00
Yes 0.42 0.28–0.64 0.001 1.34 0.68–2.65 0.4
Hemorrhagic transformation
No 1.00
Yes 3.41 1.89–6.36 0.001 2.04 0.92–4.57 0.08
Cortical stroke
No 1.00
Yes 1.84 1.28–2.65 0.001 1.33 0.78–2.27 0.3
NIHSS at admission 1.18 1.13–1.22 0.001 1.14 1.09–1.19 0.001
Hypertension
No 1.00
Yes 1.76 1.18–2.63 0.005 1.15 0.63–2.12 0.6
Atrial fibrillation
No 1.00
Yes 2.72 1.85–4.00 0.001 1.59 0.80–3.15 0.2
Hypercholesterolemia
No 1.00
Yes 0.55 0.38–0.80 0.002 0.95 0.56–1.59 0.8
Smoking
No 1.00
Yes 0.58 0.38–0.88 0.01 1.34 0.72–2.49 0.3
Hyponatremia
No 1.00
Yes 2.02 1.02–4.02 0.04 1.74 0.72–4.24 0.2
* OR was also adjusted for the following variables: IS due to large artery atherosclerosis based on TOAST classification
(p = 0.07 in univariate analysis) and hypernatremia (p = 0.08 in univariate analysis). OR = odds ratio; CI = confidence
interval; IS = ischemic stroke; ICH: intracranial hemorrhage; TOAST: Trial of ORG 10,172 in Acute Stroke Treatment;
OCSP: Oxfordshire Community Stroke Project; TACI: total anterior circulation infarction; LACI: lacunar circulation
infarction; NIHSS: National Institute of Health Stroke Scale.
3.3. Long-Term Mortality
Kaplan-Meier curves showed a no significantly higher survival rate for patients with post-stroke
seizures compared to those without seizures (36.7% versus 26.2%; p = 0.2; Figure 2). Age, NIHSS at
admission, and pre-stroke mRS were independently associated with all-cause long-term mortality at
the Cox multivariate analysis (see Table 3).
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Table 3. Cox analysis, predictors of all-cause long-term mortality.
OR 95% CI p
Age 1.07 1.05–1.08 0.001
Sex
Females 1.00
Males 1.09 0.89–1.35 0.4
Post-stroke seizures
No 1.00
Yes 0.71 0.48–1.06 0.09
Stroke subtypes
IS 1.00
ICH 1.21 0.92–1.60 0.2
NIHSS at admission 1.07 1.05–1.08 0.001
Pre-stroke mRS > 2
No 1.00
Yes 1.65 1.30–2.09 0.001
OR = odds ratio; CI = confidence interval; IS = ischemic stroke; ICH: intracranial hemorrhage; NIHSS: National
Institute of Health Stroke Scale; mRS = modified Rankin Scale.
3.4. Seizure Type and Long-Term Outcome
In Table 4, we compared prevalence of long-term disability and mortality between patients affected
by each specific type of seizure and subjects without post-stroke seizures.
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Disability, n (%) 8 (80) 379 (64.9) 0.3
Mortality, n (%) 6 (60) 436 (74.7) 0.2
SZR FA+: patients with focal aware seizures; SZR GTC+: patients with generalized tonic-clonic seizures; SZR
FBTC+: patients with focal to bilateral tonic-clonic seizures; SZR FIA+: patients with focal impaired awareness
seizures; SZR −: patients without post-stroke seizures.
4. Discussion
This study shows that patients affected by post-stroke seizures do not have a long-term unfavorable
outcome. In fact, rates of severe disability and mortality were comparable between stroke patients
with and without seizures.
Previous hospital-based studies reported that the proportion of stroke patients experiencing
seizures may vary from 1% to 25% [35]. Differently, information coming from population-based studies
is more robust and repeatable. During the study period, we observed a prevalence of post-stroke
seizures of 8%, which is perfectly in line with earlier data derived from studies performed at the
community level [35].
In a previous study, we focused on identifying risk factors for post-stroke seizures. We reported that
ICH, subarachnoid hemorrhage, stroke of undetermined origin and hyponatremia were independent
predictors of ES, while LS risk factors were younger age and cortical location of stroke [6]. In the
present study, post-stroke seizures were significantly associated with younger age, ICH and more
severe stroke as assessed by NIHSS score at admission. Moreover, patients with total anterior IS,
hemorrhagic transformation after IS, cortical strokes, and lobar ICH had a higher risk of seizures.
In 1997, Arboix et al. reported that patients with seizures were significantly younger, and this result
was replicated by Paolucci et al. in a cohort of 306 consecutive patients admitted to a rehabilitation
hospital after their first ever stroke and later by Conrad et al. in 593 consecutive patients with different
types of cerebrovascular events [12,36,37]. Similarly, in our sample the mean difference between
subjects with and without seizures was almost five years. Given that the volume of cortical gray matter
is higher in younger patients, a tentative explanation of this result was suggested to be due to the
generally weaker epileptogenicity of older brains [36]. Several previous studies reported that stroke
patients with ICH developed more frequently seizures than those with IS [14,38,39]. In a prospective
multicenter study, Bladin et al. observed that ICH patients had an almost two-fold increase in risk
of seizures after stroke [14]. Hemorrhagic transformation of IS has been found to increase the risk of
seizures. In a prospective study on 368 patients with IS it was found that risk for developing seizures
was almost 6-fold higher in subjects with hemorrhagic transformation [40]. This is usually attributed
to the epileptogenicity of blood products (especially iron). In fact, free iron is a potent oxidizer that
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damages cell membranes due to creation of reactive oxygen species, peroxidation damage to cell
membrane lipids, production of free radicals, and injury to oxidant-sensitive cellular enzymes, such
as Na, K-ATPase [41]. The effects of hemoglobin and its degradation products (hemin and iron) on
synaptic transmission was studied by Yip and Sastry in a rat model [42]. In addition, iron compounds,
such as FeCl3, have been commonly used in animal models of epilepsy due to their highly epileptogenic
effect when injected into the animal hippocampus and cortex [43,44]. It is known that seizures are
more frequent in severe and disabling strokes [11,13]. Thus, our results regarding the association
between seizure occurrence with stroke severity, based on NIHSS score at admission and presence
of total anterior circulation infarct, agree with previous literature. Finally, we observed that cortical
involvement was a risk factor for seizures in stroke patients. Several previous studies reported similar
data [14,45,46].
Since stroke is, per se, the leading cause of disability, it is essential to identify further clinical
conditions associated with the cerebrovascular accident that might affect functional outcome. To date,
only few studies investigated the role of seizure in impairing disability after stroke [13,18,19,21,22,24].
In 1990, Kilpatrick et al. evaluated prospectively 1000 consecutive patients with stroke and TIA in
order to establish incidence and consequence of ES. The authors did not show any association between
seizures and worse functional outcome at discharge [18]. These results agree with the Dijon Stroke
Registry, in which ES did not predict short-term disability after stroke [21]. In a different way, presence
of ES predicted a better outcome at discharge in patients with acute stroke in the Copenhagen Stroke
Study that adopted the Scandinavian Stroke Scale to measure stroke severity. The authors explained
this surprisingly result by a relatively larger ischemic penumbra in patients who have an ES after a
stroke [13]. The first study that used a validated tool for evaluating the effect of seizures on post-stroke
disability was published in 2010. Patients with seizures had a greater disability having a mean
mRS at discharge significantly higher than those without seizures (4.41 versus 3.15, p = 0.0001) [19].
Similarly, seizures during hospitalization after IS were associated with a higher morbidity at discharge,
as measured by the mRS, in a recent large multicenter study [22]. To date, only the Future study
investigated long-term (mean follow-up of 9.8 years) functional outcome in patients with and without
post-stroke seizures. Arntz et al. reported that IS patients with epilepsy had a higher disability than
those without it (mRS score >2: 27.5% versus 9.8%, p = 0.001). However, this result was not observed in
patients with TIA and ICH [24]. Since this study was performed in young patients with cerebrovascular
accidents, its consequences cannot be generalized. Our results, coming from a population-based
study, should be considered more robust. During a 24-month follow-up, patients with post-stroke
seizures had a poor functional outcome in unadjusted analysis, but this significant association was lost
after multivariate analysis. Indeed, age, ICH, and NIHSS score at admission resulted to be the only
independent predictors of long-term disability in our sample.
The relationship between post-stroke seizures and the risk of long-term mortality is largely
misunderstood. In fact, previous studies focused on this topic had a short-term follow-up, i.e., one
month or one year after stroke [2,13,18–22]. In 2015, Arntz et al. published new data of the Future study
on post-stroke epilepsy and long-term mortality. The authors reported that the 20-year cumulative
mortality for patients with and without post-stroke epilepsy was 56.5% and 32.6%, respectively.
After adjustment for confounders post-stroke epilepsy remained significantly associated with mortality.
As reported above, this study is limited because it enrolled only patients aged 18 to 50 years [25].
On the contrary, Claessens et al. observed that seizures after ICH were not significantly related to
mortality risk after follow-up up to 10 years [23]. Our results agree with this last survey. In fact,
long-term mortality risk did not differ in patients with and without post-stroke seizures. The not
significant slight difference in favor of a better survival for patients with post-stroke seizures may be
explained by the slight age difference between the two groups.
When we analyzed the effect of each specific type of seizure on long-term disability and mortality,
we did not observe any significant association. However, there was a trend toward a lower mortality in
patients with focal aware seizures and a higher disability in patients with focal to bilateral tonic-clonic
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seizures than in subjects without post-stroke seizures. Bearing in mind the small number of patients
with seizures included in these analyses, we think that further larger studies focused on this topic are
needed before any conclusion.
Strength of our study was the prospective design with data coming from a population-based
study after one of the longest follow-ups (up to 12 years). There are also some limitations. Because
of a long inclusion period, we cannot exclude that a recall bias might have influenced our results.
Moreover, patients may underreport focal seizures with subtle semiology, thus misdiagnosis might
have occurred. Finally, almost 12% of baseline study population was lost at follow-up and this loss
might have minimally affected the results.
Despite these limitations, we believe that our results sufficiently demonstrate that seizures do not
impair long-term disability and mortality in patients affected by cerebrovascular accidents.
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